All articles by Gustav Ando

Why are pharma prices changing?

Understanding the reasons behind medicines' price changes has been a common challenge Prices of medicines evolve over time and are…
Mixed news on COVID19 vaccines: COVID-19 R&D tracker

In the latest edition of our Weekly COVID19 R&D Tracker, which has tracked progress and expected timelines of vaccines and…
Prices of essential COVID-19 medicines have increased 4% globally since February

Prices for the 10 most critical drugs to treat COVID-19 have risen a highly unusual 4 percent globally during the…
US scrambles for resources in COVID-19 response

According to new IHS Markit data, the United States' shortage of medical supplies is being exacerbated by trade disruptions from…
ISPOR Europe 2018 Barcelona

We are at ISPOR Europe 2018 in Barcelona, Spain! We look forward to seeing you there! Please look out for…

Rapid changes in the global IRP environment

The announcement on 25 October that the US is planning to introduce international reference pricing (IRP) on Medicare Part B…
Nevermore ignore the role of digital health in health decision making

Here at the opening of the 23rd annual international meeting of ISPOR in Baltimore - 10 years after we started attending…
ISPOR 2018 Baltimore

We are pleased to announce that we will be at ISPOR 2018, 19-23 May, in Baltimore, Maryland. Please do look…
Visit us at ISPOR 2017 Glasgow!

We are pleased to announce that we will be at the 20th Annual ISPOR European Congress, 4-8 November, in Glasgow.…
US Healthcare Reform: The ISPOR Debate

Much like the Pixies, who spent the last few days playing a series of concerts on their home turf here…